Propylthiouracil Side Effects Lawsuits
Propylthiouracil Side Effects Injury Lawsuits. Propylthiouracil, a drug used to treat an overactive thyroid or Graves' disease, has been associated with severe liver injuries in both adults and children. In April 2010, the U.S. Food & Drug Administration (FDA) decided that because the liver injury risk from propylthiouracil was … [Read more...]
Viekira Pak And Technivie May Lead To Serious Liver Injury
Hepatitis C Drugs Side Effect May Lead To Death. Viekira Pak and Technivie are antiviral medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic hepatitis C. Hepatitis C is a viral infection that may last a lifetime and may also lead to serious liver and other health problems such as … [Read more...]
Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks
The use of Revolade (eltrombopag) may cause severe hepatotoxicity and potentially deadly fatal liver injury, warns Canada’s health regulator, Health Canada, according to Healthy Canadians, Government of Canada. Revolade, which is a thrombopoietin receptor agonist, is manufactured and marketed by GlaxoSmithKline under the trade name … [Read more...]
Serious Liver Injury Reported with Hepatitis C Treatments Viekira Pak and Technivie, FDA Warns
Cases of serious liver injury have been reported in patients using hepatitis C treatments Viekira Pak and Technivie, the U.S. Food and Drug Administration (FDA) warns. According to the agency's safety notification, most cases occurred in patients who already had underlying advanced liver disease. The safety label on Viekira Pak and … [Read more...]
FDA Issues Liver Injury Alert for Muscle-Building Supplement
FDA Warning Over Muscle-Building Supplement. The Food and Drug Administration (FDA) has issued a warning to consumers not to use the muscle-growth supplement Tri-Methyl Xtreme. The supplement has been linked to cases of severe liver injury. Tri-Methyl Xtreme is distributed by Extreme Products, a Las Vegas company, the Wall Street … [Read more...]
Samsca Liver Injury Risk
Samsca May Cause Liver Injury. Clinical trials have revealed drug-induced liver injury in patients taking Samsca (tolvaptan). Samsca was being tested for an unapproved use in patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD) at higher doses than the approved indication and in long-term use. The … [Read more...]
Weight Loss Supplements Risk of Liver Injury
The Risk Of Liver Injury In Weight Loss Supplements. A new study aims to underscore the risks of liver injury posed by dietary supplement products used to either lose weight or build muscle. According to a HealthDay News report this week on recent research from Drug-Induced Liver Injury Network, more than 100 cases of liver injury … [Read more...]
SlimQuick as Culprit in Woman’s Liver Injury
SlimQuick Risk Of Liver Injury. A case study published last month in the World Journal of Hepatology has concluded that a young woman who suffered a severe liver injury was likely suffering from a side effect of the herbal weight loss supplement, SlimQuick. The authors of the report concluded that green tea extract contained in … [Read more...]
Multaq Faces Canadian Review Over Liver Injury Fears
Multaq, already under review in the U.S. and Europe for a possible association with liver injury, is now being scrutinized by Canadian regulators. For now, Health Canada says that in that country, Multaq is not to be used by patients with severe liver problems. Multaq (dronedarone) is used to treat abnormal heart rhythm in … [Read more...]
Graves’ Disease Drug Linked to Liver Injury
Graves’ Disease Drug May Cause Liver Injury. Propylthiouracil, a drug used since the late 1940s to treat overactive thyroid or Graves' disease, has been linked to serious, and sometimes fatal, liver injuries in adults and children. In an alert issued yesterday, the Food & Drug Administration (FDA) said it was working to make … [Read more...]
NEW WARNINGS FOR PARKINSON’S DRUG, TASMAR
Tasmar Can Cause Fatal Liver Injury. FDA and Hoffmann-La Roche Inc., the manufacturer of the drug Tasmar for patients with Parkinson's Disease, are advising doctors about reports of a new finding of fatal liver injury associated with use of the drug, and recommending significant changes in how it is used. Because of these reports, … [Read more...]
